BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28832564)

  • 1. Haplotype-based stratification of Huntington's disease.
    Chao MJ; Gillis T; Atwal RS; Mysore JS; Arjomand J; Harold D; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF; Lee JM
    Eur J Hum Genet; 2017 Nov; 25(11):1202-1209. PubMed ID: 28832564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
    Kay C; Collins JA; Caron NS; Agostinho LA; Findlay-Black H; Casal L; Sumathipala D; Dissanayake VHW; Cornejo-Olivas M; Baine F; Krause A; Greenberg JL; Paiva CLA; Squitieri F; Hayden MR
    Am J Hum Genet; 2019 Dec; 105(6):1112-1125. PubMed ID: 31708117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-Level Analysis of the Major European Huntington Disease Haplotype.
    Lee JM; Kim KH; Shin A; Chao MJ; Abu Elneel K; Gillis T; Mysore JS; Kaye JA; Zahed H; Kratter IH; Daub AC; Finkbeiner S; Li H; Roach JC; Goodman N; Hood L; Myers RH; MacDonald ME; Gusella JF
    Am J Hum Genet; 2015 Sep; 97(3):435-44. PubMed ID: 26320893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
    Shin JW; Kim KH; Chao MJ; Atwal RS; Gillis T; MacDonald ME; Gusella JF; Lee JM
    Hum Mol Genet; 2016 Oct; 25(20):4566-4576. PubMed ID: 28172889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of the
    Apolinário TA; Rodrigues DC; Lemos MB; Antão Paiva CL; Agostinho LA
    Clin Med Res; 2020 Dec; 18(4):145-152. PubMed ID: 32878904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.
    Kay C; Collins JA; Skotte NH; Southwell AL; Warby SC; Caron NS; Doty CN; Nguyen B; Griguoli A; Ross CJ; Squitieri F; Hayden MR
    Mol Ther; 2015 Nov; 23(11):1759-1771. PubMed ID: 26201449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of Huntington's disease-affected human embryonic stem cell lines.
    Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
    Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.
    Shin A; Shin B; Shin JW; Kim KH; Atwal RS; Hope JM; Gillis T; Leszyk JD; Shaffer SA; Lee R; Kwak S; MacDonald ME; Gusella JF; Seong IS; Lee JM
    Hum Mol Genet; 2017 Apr; 26(7):1258-1267. PubMed ID: 28165127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease.
    Ramos EM; Gillis T; Mysore JS; Lee JM; Gögele M; D'Elia Y; Pichler I; Sequeiros J; Pramstaller PP; Gusella JF; MacDonald ME; Alonso I
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):135-43. PubMed ID: 25656686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability during neurogenesis in Huntington's disease.
    Ruzo A; Croft GF; Metzger JJ; Galgoczi S; Gerber LJ; Pellegrini C; Wang H; Fenner M; Tse S; Marks A; Nchako C; Brivanlou AH
    Development; 2018 Jan; 145(2):. PubMed ID: 29378824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
    Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
    Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
    Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
    J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.
    Kay C; Tirado-Hurtado I; Cornejo-Olivas M; Collins JA; Wright G; Inca-Martinez M; Veliz-Otani D; Ketelaar ME; Slama RA; Ross CJ; Mazzetti P; Hayden MR
    Eur J Hum Genet; 2017 Feb; 25(3):332-340. PubMed ID: 28000697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
    Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.
    Kim KH; Abu Elneel K; Shin JW; Keum JW; Seong D; Kwak S; Lee R; Gusella JF; MacDonald ME; Seong IS; Lee JM
    J Hum Genet; 2019 Oct; 64(10):995-1004. PubMed ID: 31296921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
    Apolinário TA; Paiva CL; Agostinho LA
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.